Finance

Lists
PTPI:OTCMKTS
Petros Pharmaceuticals Inc
$0.0042
+21.43%
(+0.00075) 1D
Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTPI...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
90.04K
Avg. vol.
119.95K
Volume
501.04K
52-wk high
$0.03
52-wk low
$0.00
EPS
-$0.31
Beta
1.89
Shares outstanding
42.37M
No. of employees
3
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
90.04K
Avg. vol.
119.95K
Volume
501.04K
52-wk high
$0.03
52-wk low
$0.00
EPS
-$0.31
Beta
1.89
Shares outstanding
42.37M
No. of employees
3
About Petros Pharmaceuticals Inc
CEO-
Employees3
Founded2020
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
990.74K
391.49K
1.03M
988.50K
Operating expense
990.74K
391.49K
1.03M
988.50K
Total operating expenses
990.74K
391.49K
1.03M
988.50K
Operating income
-990.74K
-391.49K
-1.03M
-988.50K
Other non operating income
1.00K
1.70K
-
900.00
EBT including unusual items
-922.72K
-336.51K
-987.04K
-955.62K
EBT excluding unusual items
-922.72K
-336.51K
-987.04K
-955.62K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-922.72K
-336.51K
-987.04K
-955.62K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
67.01K
53.28K
40.14K
31.98K
Interest expense
-
-
-
-
Net interest expenses
67.01K
53.28K
40.14K
31.98K
Depreciation and amortization charges
-
-
-
-
EBITDA
-282.93K
316.32K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps